David G. Watumull, Chairman and CEO

More than twenty years experience as a biotechnology industry executive, analyst, and investment banker. Co-founder of Cardax and co-inventor of Cardax technology. As CEO of Hawaii Biotech, led efforts that raised more than $25 million in equity financing and $30 million in grant funding. Started and led a West Nile virus vaccine program at Hawaii Biotech that achieved success in a human proof of concept study. View Biography >>

David M. Watumull, COO and CFO

Two decades of experience in astaxanthin product development, commercialization, and business management. Mr. Watumull oversees Cardax operations with responsibility for product development and manufacturing, sales and marketing, regulatory compliance, finance, and administration. View Biography >>